Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07257874Phase 3Completed
A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Islamabad Medical and Dental College. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07257874.